One quick thing: RBI issues draft circular on issuance of debit, credit and prepaid cards
In today’s newsletter:
Was this newsletter forwarded to you? You can sign up for Tech3 here
At long last, India is set to get its much-awaited data privacy law, as the Cabinet has approved the draft Digital Personal Data Protection bill.
The bill was designed after a lengthy consultative process, during which the government received over 23,000 suggestions from various stakeholders.
While the bill has not undergone any major changes beyond the version published last year, it is expected to have been fine-tuned in some respects.
The draft bill requires a data fiduciary, which is an entity that processes user data, to give an itemised notice to users about the data that is being collected, in clear and plain language.
Although the industry made strong representations to the government to water down a provision that restricts the use of children's data to target ads at them, the government has not budged.
Unicorns facing markdowns have been making headlines lately, but their valuations have remained unscathed as they have avoided raising funds at lower values.
However, a twist is unfolding in India as PharmEasy, a unicorn, is gearing up for a funding round at a massive haircut.
Pharmeasy is looking to raise about Rs 2,500 crore in a new funding round, a much-needed infusion for the health-tech unicorn.
Manipal Group will be leading the round with a Rs 1,000 crore fund infusion for an 18% stake in the healthtech unicorn, according to sources.
PharmEasy has had a difficult time since last year. The company shelved its plans to go public in August 2022, citing market conditions and strategic decisions. It was then seeking to raise Rs 500-600 crore internally.
It also reportedly raised a near-$300 million loan from Goldman Sachs to repay its previous loan from Kotak Mahindra Bank, which it had raised to acquire Thyrocare.
PharmEasy’s fair value has been marked down multiple times by US-based asset management companies. According to the latest filings, Janus Henderson values Pharmeasy at $2.7 billion, while Neuberger Berman has pegged its valuation at $4.4 billion.
As the two food delivery giants continue to fight it out, Zomato has slowly emerged as the leader, gaining market share at Swiggy’s expense.
Swiggy reigned supreme with a 52% market share in 2020, but that share has fallen to 45% in the past three years.
The Gurugram-based company has penetrated deeper into Tier-2 cities and beyond, and has also developed a more pan-India focus.
Additionally, Swiggy is only present in 580 cities, while Zomato serves in over 750 cities.
“With Tier 2 cities and beyond, there will be questions on revenue today versus medium-term revenue. If habit creation is not denting overall profitability, a company must chase it… where else will they get the next wave of users from?” an analyst asked.
Given that Swiggy’s losses are about 5X higher than Zomato’s, experts say the Bengaluru-based firm should have grown much bigger, but the two companies have a roughly similar topline.
Swiggy chose to build its quick commerce business, Instamart, from the ground up, while Zomato acquired Blinkit.
“A bulk of the money Swiggy raised…went into building Instamart and a lot of the management bandwidth was also focused on making Instamart huge. Zomato got the same capabilities by acquiring Blinkit (earlier Grofers),” an analyst said when asked why Zomato had an edge over its peer.
With growth taking a backseat, net employee addition at Indian unicorns fell to a fifth in the first half of 2023 from the year-ago period.
On July 5, 1994, Jeff Bezos founded Amazon from his garage in Bellevue, Washington. The company began as an online marketplace for books, but it eventually expanded into a multitude of product categories, earning it the moniker "The Everything Store."
27 years later, on the same day in 2021, Bezos stepped down as CEO of Amazon and turned the helm over to cloud-computing boss Andy Jassy.
Have you ever lost a loved one and wished you could talk to them one more time?
Well, now you can, thanks to Deepbrain AI’s Re;memory, a new AI service that lets you meet and talk with the deceased as if they were still alive. (This certainly gives us Black Mirror vibes.)
Re;memory uses photos and videos of the deceased to create an AI avatar that looks and sounds just like them. The avatar can then be programmed to have conversations with you, based on the person's personality and interests. Find out more
Note: By subscribing to Tech3 you have already made the right choice. Top it up with a premium offering, the Moneycontrol Pro Panorama, a newsletter that gives you a sharp take on macros, markets, business and finance. Sign up for Pro from this link to get this newsletter in your inbox and also a host of content enjoyed by 500,000+ subscribers.